Fabege becomes an associate partner of the Flemingsberg Science Foundation

Flemingsberg, December 19, 2023.

Flemingsberg Science Foundation announces today that Fabege is becoming an associate partner of the foundation. It marks the beginning of closer collaboration with private entities.

“We are thrilled that Fabege is becoming a partner of Flemingsberg Science! Throughout the year, we have been working on developing a partnership program that enables entry from private entities into the foundation,” says Johnny Högberg, CEO of the Flemingsberg Science Foundation.

The foundation’s strategic goals for the period 2022–2025 highlight the need to attract new partners and stakeholders to the foundation, recognizing the value of investing in both the operation and the location. The power and ability to take the next steps in developing Flemingsberg, as well as the pace at which this can be achieved, depend entirely on such developments.

“Fabege is an active participant in the development of Flemingsberg as a regional city center. It is one of Sweden’s largest development projects and a crucial part of Stockholm’s future. Flemingsberg Science serves an important role as a link between society, academia, and business. Together, we work to make Flemingsberg an attractive option for knowledge-intensive and creative industries,” says Stefan Dahlbo, CEO at Fabege.

As an associate partner, joining the foundation means aligning with its purposes. The primary focus is on the foundation’s goal for Flemingsberg to be the first choice for establishments in southern Stockholm. This expansion increases opportunities to drive projects and activities related to site development, packaging, and promoting Flemingsberg. Bringing in associate partners also means incorporating new expertise into the foundation. The foundation is now working to strengthen its ranks with more partners who recognize the value of investing in both the operation and the location of Flemingsberg.

Johnny Högberg

CEO, Flemingsberg Science

070 550 12 73

OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg

Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on the Flemingsberg Campus. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.

Drivhuset Stockholm – Where Future Entrepreneurs Take Their First Steps

Imagine a place where young ideas are free to grow, where passion meets ambition, and where the entrepreneurs of tomorrow take their first steps toward greatness. That’s exactly what Drivhuset Stockholm offers – a springboard for the next generation of entrepreneurs. Located on Campus Flemingsberg, we support students every day as they bring their ideas to life and build the skills needed to create real change. Our mission? To provide them with a safe, inspiring environment where they can test and develop their business ideas for real.

Hitchhiker’s Guide to Startup Success: Mastering the Art of the Perfect Pitch

Earlier this fall, we launched the first event in our seminar series, Hitchhiker’s Guide to Startup Success, which we are organizing together with Miltenyi Biotec. The inaugural session featured an inspiring workshop led by pitch expert and coach Malcolm Larri. The event gathered innovators and entrepreneurs in the Life Sciences sector, with a particular focus on Advanced Therapy Medicinal Products (ATMP)—a rapidly growing field with tremendous potential to revolutionize healthcare.

12 Next